Flash FinanceUS
Market closed S&P 5007,520.93-0.38% Nasdaq25,065.88-0.74% Dow 3052,231.89-0.30% Russell 20002,821.38-0.68% Nasdaq-10027,740.79-0.60% MidCap 4003,700.81-0.39% SmallCap 6001,716.22-0.36% VIX19.46-2.31% 10Y Yield4.98+2.45% Close of Nov 10, 2026
AI brief of an SEC Form 8-K · Skye Bioscience, Inc. (SKYE)

Skye Bioscience CFO John Sharp resigns; CEO Punit Dhillon takes over finance role

Mixed Impact 4 of 5 leadership Written later

Skye Bioscience's Chief Financial Officer John P. Sharp resigned effective September 8, 2026, and CEO Punit Dhillon was appointed principal financial and accounting officer. The company also gave notice to end its Master Services Agreement with Lohman & Associates on the same date, and Nasdaq confirmed the company regained compliance with the minimum bid price rule. The filing states Sharp's departure was not due to any disagreement with the auditors or the company on financial or operating matters.

Key points

  • Sharp resigned as CFO and principal financial and accounting officer effective September 8, 2026; the filing says there was no disagreement with auditors or the company on financial statements, internal controls, operations, policies or pra
  • Board appointed CEO Punit Dhillon as principal financial and accounting officer effective September 8, 2026; his employment terms are unchanged.
  • Company terminated the Master Services Agreement dated March 31, 2026 with Lohman & Associates, Inc., effective September 8, 2026.
  • Nasdaq letter received September 8, 2026 confirmed a closing bid price at or above $1.00 for 10 consecutive business days (August 24 through September 4, 2026), closing the matter.

The filing

CompanySkye Bioscience, Inc. (SKYE)
Form8-K, current report
Filed with the SECSep 11, 2026, 4:13 PM ET
Accession number0001628280-26-061558

Items reported: 1.02 Termination of Material Agreement5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.